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We interrogated the geneticmodulation ofmaternal oxytocin response and its associationwithmaternal behavior using genetic risk
scores within the oxytocin receptor (OXTR) gene. We identified a novel SNP, rs968389, to be significantly associated with maternal
oxytocin response after a challengingmother-infant interaction task (Still Face Paradigm) andmaternal separation anxiety from the
infant. Performing a multiallelic analysis across OXTR by calculating a cumulative genetic risk score revealed a significant gene-
by-environment (G × E) interaction, with OXTR genetic risk score interacting with adult separation anxiety to modulate levels
of maternal sensitivity. Mothers with higher OXTR genetic risk score and adult separation anxiety showed significantly reduced
levels of maternal sensitivity during free play with the infant.The same G×E interaction was also observed for the extended OXTR
cumulative genetic risk score that included rs968389.Moreover, the extended cumulativeOXTRgenetic risk score itself was found to
be significantly associatedwithmaternal separation anxiety as it specifically relates to the infant. Our results suggest a complexmon-
tage of individual and synergistic genetic mediators of maternal behavior. These findings add to specific knowledge about genetic
regulation ofmaternal oxytocin response in relation tomaternal adjustment and infant bonding through the first fewmonths of life.
1. Introduction
Humans are social beings who are biologically tuned to
form selective and enduring bonds with other individuals.
These social bonds provide protection and caregiving and
offer comfort during times of distress [1]. A plethora of
genetic, epigenetic, behavioral, neurological, and cognitive
processes work in unison to form these meaningful bonds
that are essential for human survival [2]. Several studies
have examined aspects of the neuroendocrinological basis for
social behavior and human bonding. Oxytocin is a neurohor-
mone implicated in the human affiliation system, particularly
involving social behaviors, parent-infant bonding [3, 4], and
maternal caregiving behavior [5]. Studies in humans [6–8]
and rodents [5, 9] have demonstrated the role of oxytocin in
maternal caregiving behavior, with higher levels observed in
securely attachedmothers after interaction with their infants.
Mothers with the highest oxytocin levels during parturition
demonstrate more attentive maternal behaviors in relation to
the infant, including gaze, vocalization, positive affect, affec-
tionate touch, frequent checking of the baby, and attachment-
related thoughts concerning the infant following birth [10].
Also, significant interindividual differences are described in
the maternal oxytocin response after interaction with the
infant, characteristics which in turn may predict differences
in the quality and extent of maternal care [11, 12]. Further,
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mothers with secure attachment styles show an increased
oxytocin response following interaction with their infants,
exhibiting greater activation of the brain reward regions and
the oxytocin-associated hypothalamus/pituitary region [6].
Our group and other researchers have found an association
between lower plasma oxytocin levels in the postpartum
period and symptoms of adult separation anxiety (ASA) and
depression in mothers; in addition, these mothers exhibited
anxious attachment styles [13]. In the same study, ASA
mediated the association between anxious attachment and
depression, while depressed mood mediated the relationship
between separation anxiety and low oxytocin levels [13].
The involvement of oxytocin in regulating the mother’s
responsive engagement with her infant has been studied
using the Still Face Paradigm (SFP) [14]. SFP is an experi-
mental paradigm initially developed to examine an infant’s
reaction to a state of unresponsiveness in the mother, and
the paradigm has subsequently been extended to the study
of a myriad of related research questions including aspects
of mother-infant interaction [15] and the creation of an
emotional challenge for the infant-mother dyad [16, 17]. In a
study examining change in plasma oxytocin levels following
interactions with the infant during the SFP condition [16],
mothers with a reduced oxytocin response demonstrated a
significant decrease in their gaze toward their infants during
periods of infant distress, while such changes were not
observed in mothers with an increased oxytocin response.
Oxytocin, however, may be associated with both positive
and adverse outcomes depending on the level of nurturance
or adversity in the early environment of an individual [3].
For instance, recent genetic studies have provided evidence
of gene-environment (G × E) interactions, such that the
SNPs within the oxytocin receptor gene (OXTR) interact
with the environment to confer risk for mental disorders and
other behavioral traits. Interaction of the OXTR genotypes
with positive behaviors such as empathy [18] and trust [19]
or, conversely, with adverse environments such as exposure
to abuse [20, 21] shapes either lower or greater risk for
depression and anxiety, respectively.
Genetic variability within the OXTR gene may modulate
risk for psychiatric and behavioral symptoms, and this may
be driven by a combination of cumulative genetic effects
across the OXTR locus. Cumulative genetic risk score across
OXTR, CD38, and AVPR1a, previously associated with psy-
chopathology, sociability, and caregiving of the mother, has
been shown to interact with trauma-exposure in children
to predict higher levels of PTSD, anxiety disorders, conduct
disorders, and ADHD [22], further supporting the role of
OXTR gene-environmental interactions.
The overarching aim of the study was to investigate
relations involving blood oxytocin levels, aspects of the
oxytocin gene, and maternal caregiving behavior. Specifi-
cally, we aimed to evaluate (a) the genetic mediators of
maternal oxytocin response following a challenging mother-
infant interaction task (i.e., SFP); test if the same genetic
mediators would be associated with (b) maternal behavior
following a mother-infant separation and interrogate (c)
whether the genetically mediated maternal behavior was
driven by separation anxiety. We hypothesized that mothers
Table 1:Demographic details of the 96women included in the study.
Variable Mean [SD]/𝑁 [%]
Age 29.90 [0.57]
Ethnicity:
Caucasian 46 [47.9%]
Asian 32 [33.3%]
Arab 12 [12.5%]
Other 6 [6.3%]
Adult separation anxiety:
Yes [≥22] 48 [50%]
No [<21] 48 [50%]
rs968389 genotype:
AA 29 [30.2%]
AG 36 [37.5%]
GG 30 [31.3%]
with a genetic predisposition to decreased maternal oxytocin
response would be more likely to exhibit reduced maternal
caregiving behavior, and this relationship would be mediated
by separation anxiety.
2. Materials and Methods
2.1. Study Participants. The study sample comprised 127
participants, selected from a larger pool of pregnant women
(𝑛 = 668) attending a general hospital antenatal clinic, the
details being provided in Eapen et al., 2014 [13]. Briefly, 668
women were screened in pregnancy using the Adult Separa-
tionAnxietyQuestionnaire (ASA-27) to assess eligibility for a
longitudinal study investigating maternal separation anxiety,
oxytocin, and bonding over the transition to parenthood.
The antenatal sample of women was sampled so as to
achieve a structured group including a balanced number
of participants with and without current separation anxiety
symptoms as indicated by the ASA-27. The study cohort of
127 women had an almost equal number of women with and
without ASA, with 27 more than the required 100 subjects, to
allow for attrition of the sample over time. From this sample
of 127 women, genotypes for OXTR SNPs were available for
a random subset of 96 women that were included in this
study. All analyses described here were performed on this
subset of 96 women. At the time of recruitment, all women
were aged over 18 years, English-speaking, and less than 38
weeks’ gestation with a singleton infant. Women provided
consent to participate in a longitudinal study and genetic
analysis investigating maternal separation anxiety, maternal
bonding, and related experiences. Demographic details of
women included in the study are provided in Table 1.
2.1.1. Procedure. Prenatally (averaging 30 weeks’ gestation),
participants completed self-report questionnaires including
the Adult Separation Anxiety Questionnaire (ASA-27) [23].
For the postnatal stage of the study (averaging 3 months
postpartum), participants again completed the ASA-27 as
well as the Maternal Separation Anxiety Scale (MSAS) [24]
and then took part in the Still Face Paradigm [14] in addition
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to providing blood samples for oxytocin measurements and
DNA for genotyping.
2.2. Questionnaires and Mother-Infant
Observational Procedure
(i)TheAdult Separation Anxiety Checklist Scale (ASA-27).The
ASA-27 is a self-report questionnaire assessing separation
anxiety symptoms in adulthood [23]. The ASA-27 contains
27 items, each answered on a four-point scale. Scores can be
summed to yield a total score, with higher scores indicating
greater separation anxiety symptom severity. The measure
has sound internal consistency (Cronbach’s alpha of 0.95). To
allow comparisons with other studies examining anxiety in
pregnancy and the unique contribution of separation anxiety
to maternal bonding and related experiences, participants
were allocated to the “separation anxiety group” if they scored
over the threshold (i.e., total ASA-27 score ≥ 22) [25] for
clinically significant symptoms or to the “without separation
anxiety group” if they scored below threshold [13].The cut-off
threshold for determining ASA was achieved by comparing
the ASA-27with a structured clinical interview for separation
anxiety disorder (Adult Separation Anxiety Semistructured
Interview: ASA-SI) that revealed a high level of concordance
suggesting that the questionnaire is an adequate alternative
measure of ASA [25].
(ii) Maternal Separation Anxiety Scale (MSAS). Maternal
separation anxiety is characterized by an unpleasant emo-
tional state resulting from a separation experience from her
child, manifested by feelings of worry, sadness, or guilt in
the mother [24]. The MSAS is a 35-item scale composed of
3 subscales assessing a mother’s concerns about separation
from her child. Subscale 1 includes items related to feelings
of worry, sadness, and guilt surrounding a separation event
and attitudes about exclusive maternal care (maternal care
giving behavior as it specifically relates to the infant including
separation from the infant). Subscale 2 measures maternal
perceptions of the child’s response to separation. Subscale 3
measures maternal feelings about employment-related sepa-
ration concerns [24].
(iii) Still Face Paradigm (SFP). The Still Face Paradigm
(SFP) [7, 24] is a robust and extensively used mother-infant
interaction procedure comprising consecutive episodes of
“free play” (3 minutes), maternal “still face” (90 seconds),
and “reunion” (2 minutes) used in this study to present
a “challenging” task for the mother-infant dyad. A trained
coder, blind to participants’ questionnaire scores and genetic
subtyping, rated maternal behaviors (“maternal sensitivity”)
during the “free play” and “reunion” episodes of the Still
Face Paradigm using the Global Scales for Mother-Infant
Interaction [26]. Specifically, maternal sensitivity was coded
using the good-poor dimension, rating the extent to which
the mother responds to her infant’s cues by appropriately
adjusting to the infant’s behavior, responding to infants’
signals, and measuring warmth and acceptance. For the SFP,
ten percent of cases were recoded by a second coder who
was also blind to participant scores on all study variables.
The intraclass correlation coefficient for the two coders for
maternal sensitivity was .73.
2.3. Experimental Procedures
Participants’ Plasma Oxytocin Extraction and Radioim-
munoassay (RIA). Detailed experimental protocols are given
in Eapen et al., 2014 [13]. The radioimmunoassay (RIA)
method used in this study was developed using inde-
pendently derived antisera and independently conducted
validations and is one of the best available methods for
plasma oxytocin estimation [27]. Blood samples were taken
before (T1) and after (T2) the Still Face Paradigm, collected
into vacutainer tubes, and then centrifuged at 3000 RPM
for 10min. Plasma supernatants were pipetted and stored
at −20∘C until extraction was performed. At the time of
extraction, 20mg heat-activated (700 uC) LiChroprep Si 60
(Merck) in 1mL distilled water was added to each sample,
mixed for 30minutes, and centrifuged.The pellet was washed
with distilled water and 0.01N acidic acid and then mixed
with 60% acetone to elude the neuropeptide, and evaporated
extracts were kept at −20∘C. The 0.05mL of assay buffer
was added and oxytocin assessed using a highly sensitive
and specific radioimmunoassay. To each aliquot, 0.05mL
antibody and 0.01mL l-labeled tracer were added and after
an incubation period of 3 days unbound radioactivity was
precipitated by activated charcoal. All evaporated plasma
extracts to be comparedwere treated identically to reduce any
technical artefacts during the experiment.The detection limit
is in the 0.5 pg/sample range and antiserum cross-reactivity
of less than 0.7%. Samples were analyzed at the Max Plank
Institute of Psychiatry, Munich, Germany [28].
OXTR Sequencing. OXTR sequencing was performed by
AGFR Genomics Facility using their standard protocols.
Sequencing was performed using MiSeq Reagent Kit v2 (500
cycles) 2 × 250 bp paired end reads. Image analysis was
performed in real time by theMiSeq Control Software (MCS)
v2.5.0.5 and Real Time Analysis (RTA) v1.18.54, running
on the instrument computer. Then the Illumina bcl2fastq
1.8.4 pipeline was used to generate the sequence data. The
data generated met the AGRF quality standards. A total of
12 million reads were generated with >92% aligning to the
human genome.
2.4. Statistical Procedures. Raw genotype data were exported
and converted to standard genotype calls. All data analysis
was performed using plink and R. Linear regression models
in R were fitted for covariates of age and ethnicity. Quality
checks removed ambiguous SNPs, SNPswithminor allele fre-
quency (MAF) < 10%, and deviations from Hardy Weinberg
equilibrium (HWE 𝑝 value < 0.000001). All models used the
additive SNP models. This allowed a total of 19 OXTR SNPs
that were used in further analysis. Applying amultiple testing
correction, this corresponds to a corrected 𝑝 value of 0.05/19
= 0.00263∗ Bonferroni threshold.
Imputation was performed using the minimac3 via the
Michigan imputation server (https://imputationserver.sph
.umich.edu/index.html). Filtering was done for MAF of 10%
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Figure 1: OXTR and maternal oxytocin response, MSAS total scores, and maternal separation anxiety. SNP rs968389 within the OXTR gene
was significantly associated with maternal oxytocin response (change in oxytocin levels following the SFP) ((a) 𝑝 = 0.0023∗∗, R2 = 9.1%),
total MSAS scores ((b) 𝑝 = 0.033∗, R2 = 3.9%), and maternal separation anxiety from the infant ((c) 𝑝 = 0.014∗, R2 = 4.9%). ∗ indicates
statistical significance at 𝑝 values <0.05, while ∗∗ indicates 𝑝 < 0.01.
and R2 of 0.20. The 3 OXTR SNPs previously reported by
Feldman et al., 2014, were extracted from the imputed filtered
dataset [22]. In line with Feldman et al., a cumulative genetic
risk score forOXTRwas calculated across rs53576, rs2254298,
and rs1042778 (G) which has been previously associated with
parental sensitivity and parent-child reciprocity. For each
OXTR SNP, the genotypes were divided into “high risk” and
“low risk” groups as described by Feldman et al., 2014. The
cumulative genetic risk was computed for each individual by
combining the number of high-risk genotypes on each of the
SNPs and summing it across all theOXTRSNPs. An extended
cumulative genetic risk score across the 3 OXTR SNPs and
rs968389 was calculated using the allele associated with lower
oxytocin levels as the risk group.The clinical cut-off (≥22) for
the ASA-27 (adult separation anxiety) was used to group the
environmental factor (E) adult separation anxiety as binomial
[25]. For MSAS, analysis was performed for each individual
subscale as well as for the total MSAS score. Depending on
the variable of interest, linear or logistic regressions were
performed for the main and gene-environmental interaction
models, after correction for covariates, using standard glm
functions in R. Coefficients of determination (adjusted R2)
were extracted to indicate the proportion of the variance in the
dependent variable explained by the independent variable.
To confirm that the SNP identified in this study had
functional consequences, we queried previous databases and
publications for functional evidence. We used the Genotype-
Tissue Expression (GTEx) project data (http://www.gtex-
portal.org/home/) and the UK Brain Expression Consortium
data (http://www.braineac.org/) to evaluate functional evi-
dence for the SNP identified in this study. These databases
allow assessing genetic variation within the genomes by
analyzing global RNA expression within individual tissues
and identifying variations in gene expression that are highly
correlated with genetic variation, also known as expression
quantitative trait loci, or eQTLs.
3. Results
3.1. Genetic Modulation of Oxytocin Levels after a Still Face
Paradigm and Association with Maternal Separation Anxiety
from the Infant. First, we sought to identify SNPs within the
OXTR gene that significantly regulated maternal oxytocin
response (difference in oxytocin levels before and after the
SFP). An association analysis was performed using sequenc-
ing data that was available for a total of 19 independent
OXTR SNPs. Of the 19 tested SNPs, one SNP within the
OXTR, rs968389, was significantly associated with maternal
oxytocin response (𝑝 = 0.0023∗∗, R2 = 9.1%), even after
Bonferroni correction for multiple testing (Figure 1(a)) and
after correcting for covariates of age and ethnicity (𝑝 =
0.00259∗∗).
Given the known association between oxytocin and
maternal caregiving behavior, next, we tested the relationship
between this SNP and maternal behavior specifically related
to the care of the infant including separation anxiety as mea-
sured by the MSAS subscales. The rs968389 was significantly
associated with the total MSAS scores (𝑝 = 0.033∗, R2 =
3.9%) and specifically with maternal care behavior including
when separating from the infant (𝑝 = 0.014∗, R2 = 4.9%;
see Figure 1). No significant association was observed for
maternal perception of the child’s response to separation
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Figure 2: Significant G×E observed for adult separation anxiety and
OXTR cumulative genetic risk score on maternal sensitivity. Moth-
erswith higherOXTRgenetic risk score and adult separation anxiety
tend to have reduced levels of maternal sensitivity (𝑝 = 0.007∗∗);
group means are depicted to indicate the trend. ∗∗ indicates 𝑝 <
0.01.
nor maternal feelings about employment-related separation
concerns (𝑝 > 0.05).
3.2. Cumulative Genetic Risk of Oxytocin Receptor Gene and
𝐺 × 𝐸 on Maternal Sensitivity. In line with Feldman et
al. [22], we calculated the cumulative genetic risk score
across the 3 OXTR SNPs used in the Feldman study. The
cumulative genetic risk score of OXTR was not associated
with the totalMSAS scores nor with the subscales ofmaternal
separation anxiety from the infant, maternal perception of
the child’s response to separation, or maternal feelings about
employment-related separation concerns (𝑝 > 0.05). Nev-
ertheless, mothers with a higher OXTR cumulative genetic
risk score showed significantly decreased levels of observed
maternal sensitivity as measured during the free play and the
reunion episodes of the SFP (𝑝 = 0.038∗, R2 = 8.4%).
We next questioned whether the association between the
genetic risk score and maternal sensitivity was driven by
anxiety, using assignment to high or low adult separation anx-
iety group as measured by the ASA-27. We tested “evocative”
gene-environment interaction [29] using ASA and found a
significant G × E association between the OXTR cumulative
genetic risk score and adult separation anxiety assignment
on observed maternal sensitivity during free play of the SFP
(𝑝 = 0.007∗∗, R2 = 14%, Figure 2).
Next, we calculated an extended cumulative genetic risk
score across the 3 OXTR SNPs and rs968389, the SNP that
we identified to be significantly associated with maternal
oxytocin response after the SFP, as shown above. A significant
G × E association was observed between OXTR extended
cumulative genetic risk score and adult separation anxiety
assignment on the ASA-27 on observed maternal sensitivity
during free play (𝑝 = 0.035∗, R2 = 5.4%) of the SFP, similar
to that observed above with the cumulative risk score from
Feldman and colleagues. In addition, the extended OXTR
cumulative genetic risk score was also significantly associated
with total MSAS scores (𝑝 = 0.039∗, R2 = 3.6%) and
the subscale measuring maternal separation anxiety from the
infant (𝑝 = 0.022∗, R2 = 3.6%); however, this association was
mainly driven by SNP rs968389.
4. Discussion
In this study, we interrogated the genetic and environmental
modulation of maternal oxytocin response and tested its
association with observed maternal behaviors using single
and multilocus genetic risk scores within the OXTR gene.
Our results suggest that maternal oxytocin response is
genetically regulated and we identified a SNP within the
OXTR gene rs968389 that was significantly associated with
changes in oxytocin levels following the SFP. Additionally,
this same SNPwas found to be associatedwith attitudes about
exclusive maternal care and maternal separation anxiety
as it relates specifically to the infant, highlighting its role
in maternal behavior. While most mothers are likely to
experience some anxiety at separation from their infant, some
women experience intense apprehension and concern [30],
resulting in detrimental outcomes formaternal psychological
functioning, infant development, and overall family func-
tioning [24]. As expected, mothers with reduced oxytocin
response had increased levels of maternal separation anxiety
from the infant. To the best of our knowledge, this is the first
report indicating this SNP inmaternal oxytocin response and
maternal behavior.
Using the publicly available GTeX database [31] and
the Braineac database of the UK Brain Expression Con-
sortium (http://www.braineac.org/), we found that rs968389
was significantly associated with gene expression of the
OXTR gene within the caudate (basal ganglia) brain tissue
(𝑝 value = 1.7𝐸 − 8) as well as the frontal cortex (𝑝
value = 8.7𝐸 − 7) among others, providing evidence of
functional consequences of the SNP (see Supplementary
Figures 1a and 1b in Supplementary Material available
online at http://dx.doi.org/10.1155/2016/5740365). Moreover,
the identified SNP rs968389 is also in high LD (R2 =
0.9) with another SNP rs237897, and this SNP was recently
reported to significantly influence DNA methylation levels
for two CpG sites (𝑝 < 0.05) within the OXTR gene [32].
Gene regulatory mechanisms are constantly influenced by
environmental factors that have the ability to interact with the
underlying genotype to dynamically regulate protein activity,
thereby influencing oxytocin signaling processes.
We extended the work of Feldman and colleagues by
using a similar approach and building a cumulative genetic
risk score across four SNPs within OXTR, previously asso-
ciated with social and maternal behavior [22]. In addition
to classical gene-environment interactions, “evocative” gene-
environment interactions that explain how heritable traits
may shape the environment by evoking specific reaction of
others and hence the environment provided by others [29]
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have been studied in mother-child relationships [33]. For
instance, a mother with separation anxiety may be creating
a unique environment around her by virtue of her ASA
and this adverse environment may in turn lead to specific
maternal behaviors in response to her infant; hence we tested
evocative gene-environment interactions using ASA as the
environment. Our results supported a significant G × E
association between OXTR cumulative genetic risk score
and assignment to high and low adult separation anxiety on
observedmaternal sensitivity during the free play stage of the
SFP, such that mothers with a higher cumulative genetic risk
score and with high separation anxiety showed significantly
decreased levels of maternal sensitivity compared to mothers
with higher cumulative genetic risk score and low separation
anxiety. Building upon the published cumulative genetic
risk score, we calculated an extended OXTR genetic risk
score by adding in the risk information from rs968389, an
independent SNP locus which we found to be implicated in
maternal oxytocin response and maternal separation anxiety
from the infant. Using this extended cumulative genetic
risk score, we replicated the G × E association between
OXTR cumulative genetic risk score and adult separation
anxiety (high versus low) on observed maternal sensitivity
during free play. Furthermore, we identified that the extended
OXTR cumulative genetic risk score itself was significantly
associated with maternal separation anxiety from the infant;
however this association was driven specifically by rs968389.
These results suggest a complex mosaic of individual and
synergistic genetic effects of OXTR on different aspects of
maternal behavior.
While several interesting and novel findings emerge from
this study, there are some limitations. The small sample
size and candidate-based approach suggest that it would be
important to replicate these findings in larger samples while
also performing an unbiased genome-wide scan to identify
polygenic predictors of maternal oxytocin response and
maternal behavior. However, the use of a high-risk targeted
sample such as the one used for the current study might
present an adequate target for highly specialized analysis
targeting G × E interactions in well-defined loci.
In summary, we identify a novel SNP, rs968389, that is
associated with maternal oxytocin response and maternal
behavior. These results contribute to a better understanding
of the neurobiological underpinnings of oxytocin and its role
in maternal and infant behavior with consequent implica-
tions formother-infant interactions and potential therapeutic
interventions that would merit further research.
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